Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

4

SEC Filing Details

Document Details

Form
Filing Date
Mar 11, 2019
Document Date
Mar 7, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.
Filer
BOLNO PAUL